298 related articles for article (PubMed ID: 19359367)
1. Neurotensin inhibition of GABAergic transmission via mGluR-induced endocannabinoid signalling in rat periaqueductal grey.
Mitchell VA; Kawahara H; Vaughan CW
J Physiol; 2009 Jun; 587(Pt 11):2511-20. PubMed ID: 19359367
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin exerts an effect via the endocannabinoid system to inhibit GABAergic transmission in midbrain periaqueductal gray.
Mitchell VA; Jeong HJ; Drew GM; Vaughan CW
Neuropsychopharmacology; 2011 Aug; 36(9):1801-10. PubMed ID: 21525858
[TBL] [Abstract][Full Text] [Related]
3. Glutamate spillover modulates GABAergic synaptic transmission in the rat midbrain periaqueductal grey via metabotropic glutamate receptors and endocannabinoid signaling.
Drew GM; Mitchell VA; Vaughan CW
J Neurosci; 2008 Jan; 28(4):808-15. PubMed ID: 18216189
[TBL] [Abstract][Full Text] [Related]
4. Endocannabinoids control vesicle release mode at midbrain periaqueductal grey inhibitory synapses.
Aubrey KR; Drew GM; Jeong HJ; Lau BK; Vaughan CW
J Physiol; 2017 Jan; 595(1):165-178. PubMed ID: 27461371
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoid- and mGluR5-dependent short-term synaptic depression in an isolated neuron/bouton preparation from the hippocampal CA1 region.
Sheinin A; Talani G; Davis MI; Lovinger DM
J Neurophysiol; 2008 Aug; 100(2):1041-52. PubMed ID: 18497350
[TBL] [Abstract][Full Text] [Related]
6. Capsaicin in the periaqueductal gray induces analgesia via metabotropic glutamate receptor-mediated endocannabinoid retrograde disinhibition.
Liao HT; Lee HJ; Ho YC; Chiou LC
Br J Pharmacol; 2011 May; 163(2):330-45. PubMed ID: 21232043
[TBL] [Abstract][Full Text] [Related]
7. Substance P drives endocannabinoid-mediated disinhibition in a midbrain descending analgesic pathway.
Drew GM; Lau BK; Vaughan CW
J Neurosci; 2009 Jun; 29(22):7220-9. PubMed ID: 19494144
[TBL] [Abstract][Full Text] [Related]
8. Muscarinic modulation of synaptic transmission via endocannabinoid signalling in the rat midbrain periaqueductal gray.
Lau BK; Vaughan CW
Mol Pharmacol; 2008 Nov; 74(5):1392-8. PubMed ID: 18678620
[TBL] [Abstract][Full Text] [Related]
9. Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro.
Vaughan CW; Connor M; Bagley EE; Christie MJ
Mol Pharmacol; 2000 Feb; 57(2):288-95. PubMed ID: 10648638
[TBL] [Abstract][Full Text] [Related]
10. Repeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission within the rat periaqueductal grey.
Wilson-Poe AR; Lau BK; Vaughan CW
Br J Pharmacol; 2015 Jan; 172(2):681-90. PubMed ID: 24916363
[TBL] [Abstract][Full Text] [Related]
11. Group I metabotropic glutamate receptors inhibit GABA release at interneuron-Purkinje cell synapses through endocannabinoid production.
Galante M; Diana MA
J Neurosci; 2004 May; 24(20):4865-74. PubMed ID: 15152047
[TBL] [Abstract][Full Text] [Related]
12. Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition.
Ho YC; Lee HJ; Tung LW; Liao YY; Fu SY; Teng SF; Liao HT; Mackie K; Chiou LC
J Neurosci; 2011 Oct; 31(41):14600-10. PubMed ID: 21994376
[TBL] [Abstract][Full Text] [Related]
13. Labetalol facilitates GABAergic transmission to rat periaqueductal gray neurons via antagonizing beta1-adrenergic receptors--a possible mechanism underlying labetalol-induced analgesia.
Xiao C; Zhou C; Atlas G; Delphin E; Ye JH
Brain Res; 2008 Mar; 1198():34-43. PubMed ID: 18262504
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey.
Kawahara H; Drew GM; Christie MJ; Vaughan CW
Br J Pharmacol; 2011 Jul; 163(6):1214-22. PubMed ID: 21175570
[TBL] [Abstract][Full Text] [Related]
15. Activation of type 5 metabotropic glutamate receptors and diacylglycerol lipase-α initiates 2-arachidonoylglycerol formation and endocannabinoid-mediated analgesia.
Gregg LC; Jung KM; Spradley JM; Nyilas R; Suplita RL; Zimmer A; Watanabe M; Mackie K; Katona I; Piomelli D; Hohmann AG
J Neurosci; 2012 Jul; 32(28):9457-68. PubMed ID: 22787031
[TBL] [Abstract][Full Text] [Related]
16. Cholecystokinin and neurotensin inversely modulate excitatory synaptic transmission in the parabrachial nucleus in vitro.
Saleh TM; Kombian SB; Zidichouski JA; Pittman QJ
Neuroscience; 1997 Mar; 77(1):23-35. PubMed ID: 9044371
[TBL] [Abstract][Full Text] [Related]
17. Modulation of pyramidal cell output in the medial prefrontal cortex by mGluR5 interacting with CB1.
Kiritoshi T; Sun H; Ren W; Stauffer SR; Lindsley CW; Conn PJ; Neugebauer V
Neuropharmacology; 2013 Mar; 66():170-8. PubMed ID: 22521499
[TBL] [Abstract][Full Text] [Related]
18. Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro.
Vaughan CW; Christie MJ
J Physiol; 1997 Jan; 498 ( Pt 2)(Pt 2):463-72. PubMed ID: 9032693
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoids contribute to metabotropic glutamate receptor-mediated inhibition of GABA release onto hippocampal CA3 pyramidal neurons in an isolated neuron/bouton preparation.
Inada H; Maejima T; Nakahata Y; Yamaguchi J; Nabekura J; Ishibashi H
Neuroscience; 2010 Feb; 165(4):1377-89. PubMed ID: 19961906
[TBL] [Abstract][Full Text] [Related]
20. Retrograde release of endocannabinoids inhibits presynaptic GABA release to second-order baroreceptive neurons in NTS.
Chen CY; Bonham AC; Dean C; Hopp FA; Hillard CJ; Seagard JL
Auton Neurosci; 2010 Dec; 158(1-2):44-50. PubMed ID: 20580326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]